InvestorsHub Logo

runncoach

09/25/22 8:31 AM

#20241 RE: Cyosol #20240

Certainly they would apply But we don't know how many patients from each group had to withdraw from memantine or had not been on it for some period of time already. As you say larger numbers will help but at this point it's the best explanation I've seen. I think inthetrenches summed that theory up as good as possible about a month ago on this board. Simply a theory of course

InTheTrenches

09/26/22 11:53 AM

#20242 RE: Cyosol #20240

"Any potential effects from withdrawing Memantine use before the trial would also apply to the Bryo group..."

Not necessarily. Trial imbalance in last trial could explain.

One hypothetical scenario (mistakenly stated "MMSE" instead of "SIB"):

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169853097